The government shutdown is creating a backlog of hundreds of medical device applications awaiting review at the Food and Drug Administration, triggering a cascade of delays for medical technology, The Advanced Medical Technology Association (AdvaMed) s…
Delivering drugs through a patch sounds good. But can you make money investing in it? Not likely. But a Quebec company is working with Tilray to get you a Cannabis high via oral film.
2018 stands out not only for the sheer volume of new drug approvals, but also for their quality, and the affirmation of several important trends that make it a watershed. There is every reason to believe that pharmaceutical innovation is shifting into …
Medical device makers are pushing for a change in the federal anti-kickback statute to allow companies to fully participate in the shift away from fee-for-service medicine to value-based care.
Recent months have seen a surge in opioid-related lawsuits against pharmaceutical companies and individual leadership of pharma, as well as retail pharmacies and dispensaries. Interestingly, they are being filed by cities, counties, state’s attorneys g…
China’s latest retaliatory tariffs have hit $4.7 billion in U.S. medical technology exports, the Advanced Medical Technology Association (AdvaMed) said.